CN104323153A - 降三高保健食品 - Google Patents
降三高保健食品 Download PDFInfo
- Publication number
- CN104323153A CN104323153A CN201410679399.0A CN201410679399A CN104323153A CN 104323153 A CN104323153 A CN 104323153A CN 201410679399 A CN201410679399 A CN 201410679399A CN 104323153 A CN104323153 A CN 104323153A
- Authority
- CN
- China
- Prior art keywords
- parts
- black
- cleaned
- make
- health food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013402 health food Nutrition 0.000 title abstract description 13
- 206010020772 Hypertension Diseases 0.000 title abstract description 9
- 230000001603 reducing effect Effects 0.000 title abstract description 7
- 201000001421 hyperglycemia Diseases 0.000 title abstract description 5
- 201000005577 familial hyperlipidemia Diseases 0.000 title abstract description 4
- 235000021419 vinegar Nutrition 0.000 claims abstract description 24
- 239000000052 vinegar Substances 0.000 claims abstract description 24
- 241000233866 Fungi Species 0.000 claims abstract description 13
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 13
- 244000017020 Ipomoea batatas Species 0.000 claims abstract description 13
- 235000002678 Ipomoea batatas Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 230000036541 health Effects 0.000 claims abstract description 12
- 239000004006 olive oil Substances 0.000 claims abstract description 12
- 235000008390 olive oil Nutrition 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 9
- 244000068988 Glycine max Species 0.000 claims description 20
- 235000010469 Glycine max Nutrition 0.000 claims description 20
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 16
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 240000000249 Morus alba Species 0.000 claims description 12
- 235000008708 Morus alba Nutrition 0.000 claims description 12
- 240000007164 Salvia officinalis Species 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 235000005412 red sage Nutrition 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 10
- 244000046146 Pueraria lobata Species 0.000 claims description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 238000009461 vacuum packaging Methods 0.000 claims description 5
- 241000722948 Apocynum cannabinum Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 32
- 210000004369 blood Anatomy 0.000 abstract description 31
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 230000006870 function Effects 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 8
- 210000004556 brain Anatomy 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 5
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 3
- 208000001130 gallstones Diseases 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 208000007536 Thrombosis Diseases 0.000 abstract description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241000185686 Apocynum venetum Species 0.000 abstract 1
- 241001107116 Castanospermum australe Species 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 235000021279 black bean Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 230000023555 blood coagulation Effects 0.000 abstract 1
- 230000003833 cell viability Effects 0.000 abstract 1
- 238000007599 discharging Methods 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 229940088594 vitamin Drugs 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 10
- 239000011782 vitamin Substances 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 10
- 150000003722 vitamin derivatives Chemical class 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 241000722949 Apocynum Species 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 241001065361 Gynostemma Species 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010048010 Withdrawal syndrome Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种降三高保健食品，其特征在于按重量份计，其原料配比包括醋黑豆40-60份，大枣5-15份，黑芝麻5-15份，桑叶5-15份，黑木耳20-40份，葛根粉20-40份，罗布麻5-15份，酒炙丹参3-10份，红薯叶10-20份，绞股蓝15-25份，橄榄油适量，通过以上材料晾干后放入粉碎机中粉碎，过筛网，再用橄榄油调好干湿度后，使其成为小颗粒，晾干即可，本发明通过采用上述药食同源的原料，各组分协同作用，共同发挥抗血凝、抗血栓、将血脂，同时能清除体内垃圾及时排出、分解胆固醇、预防胆结石的形成，具有增强细胞活性、提高大脑机能、活化人体细胞、改善睡眠、延缓衰老、保健作用显著等优点。
Description
技术领域
本发明涉及保健食品，具体地说是一种将血压、血脂和血糖三高的保健食品。
背景技术
众所周知，“三高症”是指高血压、高血糖(糖尿病)和高血脂症。它们是现代社会所派生出来的“富贵病”，可能单独存在，也可能相互关联。如 ：糖尿病人很容易同时患上高血压或高血脂症，而高血脂又是动脉硬化形成和发展的主要因素，动脉硬化患者血管弹性差加剧血压升高，所以后期都形成了“三高症”。有关统计资料表明，在中国人的十大死亡原因中，与代谢疾病相关的死亡率就高达35.7%，与“三高”相关的死亡人数也占总死亡人数的27%。高血脂可以引起血管栓塞 ；高血压可以引起脑出血和脑血管破裂 ；高血糖可以引起糖尿病。世界卫生组织曾经明确提出，防止心血管病的第一道防线就是减少“三高”和控制“三高”。临床对三高的治疗，现在一般用西药降压降糖降脂药，这些药物一般副作用大，往往一旦服用便需终生服用，不能达到标本兼治的目的，而且有些药物还有停药反应，所以，如何利用中医基础理论，结合中药材的优势，发明一种疗效显著、副作用小、能解决问题的代用茶。
在保健食品中，人们越来越多的采用醋黑豆进行保健，因为醋黑豆对心血管很有利，经检索CN 103330154公开了一种保健醋黑豆及其制作方法，其主要将黑豆煮熟后烘干再用醋浸泡，这种做法的不足是：黑豆的微量元素和维生素在蒸煮过程中受到不同程度的破坏，降低了黑醋的保健作用。
通过调节人体机能平衡来防病治病是中医学的特色。在丰富的祖国医药宝库中，运用药食同源的中草药对三高症进行保健调理具有独到之处。目前市场上此类保健品种类繁多，但真正起到良好效果的则很少。因此，目前，人们很需要一种降低三高、提高生活品质、无毒副作用的保健食品。
发明内容
本发明的目的是解决上述现有技术的不足，提供一种无毒副作用、营养均衡、软化血管、提高血液的通透性、降三高、养脾胃、提高免疫力、抑制脂肪堆积的降三高保健食品。
本发明解决其技术问题所采用的技术方案是：
一种降三高保健食品，其特征在于按重量份计，其原料配比包括醋黑豆40-60份，大枣5-15份，黑芝麻5-15份，桑叶5-15份，黑木耳20-40份，葛根粉20-40份，罗布麻5-15份，酒炙丹参3-10份，红薯叶10-20份，绞股蓝15-25份，橄榄油适量，
其制备步骤包括：（1）将黑豆洗净，去除杂质，用开水过两遍后沥干水分，放入大口容器内，不超过容积的三分之二，然后加入米醋到瓶口，浸泡一个月，这时醋醋几乎全部被大豆吸收，然后晾晒干燥，放在粉碎机中粉碎，用100至200目筛网过滤，制成醋黑豆粉；
（2）大枣去核洗净，焙干，黑芝麻洗净炒熟，桑叶洗净晾干，黑木耳洗净晾干，酒炙丹参切片洗净晾干，红薯叶洗净晾干，绞股兰洗净晾干，将上述材料放入粉碎机中粉碎，用100至200目筛网过筛制成粉剂；
（3）将步骤2和步骤3中制成的粉剂和在一起，混合均匀后用橄榄油调好干湿度，以使粉剂滚成团，用10目筛网过筛，制成颗粒后在阴凉处晾晒，使其干燥；
（4）将步骤3中晾晒干燥后的颗粒按10克一袋真空包装，制成成品。
用法用量：每日坚持使用一至两袋，日久必会收到意想不到的好效果。
本发明方解：
所述醋黑豆:黑豆本身味干性平，有解表清血、平肝补肾、壮阴补虚，黑发，含有丰富的蛋白质，多种矿物质及微量元素，醋黑豆能美容、减肥、将血脂，舒肝明目、补肾乌发，防癌抗衰老，对亚健康、高血脂、高血压，痛风、糖尿病、冠心病、须发早白、女性黄褐斑、肾虚耳鸣及大便干结都有补益效果，长期食用效果更佳，对于长期看电视电脑引起的视力下降、眼睛疼痛干涩，头晕头疼等症状都有改善，同时醋泡黑豆对于改善近视等眼部疾病有很好的作用，黑豆中有抗氧化成分的花青素和对口眼有益的维生素a，醋能促进黑豆中营养成分溶出，有助于豆中营养成分的吸收，豆中的维生素e和b族维生素能很好的保留，对治疗慢性疲劳、寒症、肩膀疼痛及免疫力低下，都有一定效果。而醋本身也有醋酸、钙、铁、葡萄酸、乳酸、甘油酯肪酸和盐类，它可以溶解食物中的钙、铁，使人体易吸收，能保持食物中的营养不破坏，能消化食物中的糖和脂肪，减少盐类的摄取，能降低血压和血清蛋固醇，醋泡黑豆使黑豆和醋的功效相加，效益倍增，能防大脑老化。因黑豆中有蛋黄素，能健脑益智，防止大脑老化，还有能提高强化脑细胞功能的物质，含有的微量元素能延缓脑机体的衰老，降低血液粘稠度，保持身体功能完整；
所述大枣：大枣含蛋白质、脂肪、糖份、胡萝卜素，维生素b、维生素c、维生素p、钙、磷、铁等，素有维生素丸之称。红枣中有环磷酸腺苷，能增强肌力，消除疲劳，扩张血管，增强心肌收缩力，改善心肌营养，对防治心血管病有良好作用。大枣能补虚益气，养血安神，健脾和胃，对脾胃虚弱、气血不足、倦怠乏力、失眠等患者都有良好的补益作用，对慢性肝炎、肝硬化、贫血等都有良好的疗效，还有抗过敏、抗肝癌的功效；
所述黑芝麻：黑芝麻性味甘平，归肝肾大肠经，能补益肝肾，益精血、润肠燥，用于头昏眼花、耳鸣耳聋、须发早白、病后脱发、肠燥便秘。含有大量的氨基酸及维生素e和维生素b1，能加速人体代谢；含铁和维生素e，能防贫血；活化脑细胞，消除血管内胆固醇。含不饱和脂肪酸，延年益寿，所含卵磷脂能分解胆固醇，防止胆结石形成，同时能健脑益智、延年益寿；
所述桑叶：桑叶清肺润燥、清肝明目，能抗病原微生物，能降血糖、降血压、降血脂及利尿。能滋阴养血、养阴生津、补虚润燥、疏风散寒、解表清热。
所述黑木耳：黑木耳益气健脾，滋肾养胃及活血功能，能抗血凝，抗血栓，降血脂，降低血液黏稠度，软化血管，使血液流动通畅，减少血管病发生，有较强强的吸附作用，能促使体内垃圾及时排出，对结石有较好的化解功能，能抗氧化，使人延年益寿，能减肥，所含植物胶质能促进肠蠕动，排出肠道脂肪，减少脂肪吸收，防止血液胆固醇沉积和凝结的作用，对脑血管和冠心病都有益。
所述葛根粉：葛根粉所含黄酮能调节内分泌，可治疗因雌激素下降引起的高血脂、骨质疏松等更年期综合症，保护心血管、防乳腺癌、子宫内膜癌，能改善失眠便秘，所含蛋白质、硒、铁、锌、钙、葛根素、大豆黄甙、维生素和微量元素，是天然雌激素，有养颜、护肤、丰胸、美体、抗衰老的功效；
所述罗布麻：含斛皮素、云香甙、强心甙三大活性物质及微量元素，常饮能改善血管脆性和退萎性，清除自由基，减少血管壁脂类及盐碱性化合物结晶，恢复血管弹性，延缓血管衰老，抑制高血压，还能调节血脂。含有黄酮类物质，能消除氧自由基，抗心律失常，防心肌缺血，缓解心绞痛，改善心功能，改善心缺血，能安神，解酒毒，解烟毒，抗过敏，抗病毒，润肠通便；
所述酒炙丹参：酒炙丹参能活血调经，祛瘀止疼，清心止烦，养血安神，能扩张冠状动脉，增加血流量，改善心肌缺血，提高耐缺氧和耐高血压的作用，能抑制血小板聚集，改善微循环；
所述红薯叶：红薯叶富含蛋白质、维生素a、维生素b2，维生素c和铁、钙，常吃预防便秘，保护视力，保持人体细腻，延缓衰老，可防止心血管脂肪沉积，促进胆固醇排泄，提高人体免疫力；
所述绞股蓝：绞股蓝又名长寿草，能抗动脉硬化，抑制血栓形成，对高血压、高血脂、高血糖都有一定的降低效果，能安神养性，改善脑力，增强大脑机能，活化人体细胞，改善睡眠，延缓衰老，能增强细胞活性，提高免疫力。可抑制脂肪堆积，起到减肥瘦身的作用，通便乌发，对老年便秘者也是福音。
本发明通过采用上述药食同源的原料，使其各原料组分协同作用，共同发挥抗血凝、抗血栓、将血脂、将血液粘稠度、软化血管、减少血管病发生、同时能清除体内垃圾及时排出、分解胆固醇、预防胆结石的形成，具有增强细胞活性、提高该晒大脑机能、活化人体细胞、改善睡眠、延缓衰老、营养全面、保健作用显著等优点。
具体实施方式
下面结合具体实施例对本发明进一步说明：
实施例1：一种降三高保健食品，其特征在于按重量份计，其原料配比包括醋黑豆50份，大枣10份，黑芝麻10份，桑叶10份，黑木耳30份，葛根粉30份，罗布麻10份，酒炙丹参5份，红薯叶15份，绞股蓝20份，橄榄油适量，
其制备步骤包括：（1）将黑豆洗净，去除杂质，用开水过两遍后沥干水分，放入大口容器内，不超过容积的三分之二，然后加入米醋到瓶口，浸泡一个月，这时醋醋几乎全部被大豆吸收，然后晾晒干燥，放在粉碎机中粉碎，用100至200目筛网过滤，制成醋黑豆粉；（2）大枣去核洗净，焙干，黑芝麻洗净炒熟，桑叶洗净晾干，黑木耳洗净晾干，酒炙丹参切片洗净晾干，红薯叶洗净晾干，绞股兰洗净晾干，将上述材料放入粉碎机中粉碎，用100至200目筛网过筛制成粉剂；（3）将步骤2和步骤3中制成的粉剂和在一起，混合均匀后用橄榄油调好干湿度，以使粉剂滚成团，用10目筛网过筛，制成颗粒后在阴凉处晾晒，使其干燥；（4）将步骤3中晾晒干燥后的颗粒按10克一袋真空包装，制成成品。
实施例2：一种降三高保健食品，其特征在于按重量份计，其原料配比包括醋黑豆40份，大枣15份，黑芝麻15份，桑叶15份，黑木耳40份，葛根粉40份，罗布麻5份，酒炙丹参10份，红薯叶10份，绞股蓝15份，橄榄油份，其制备步骤包括：（1）将黑豆洗净，去除杂质，用开水过两遍后沥干水分，放入大口容器内，不超过容积的三分之二，然后加入米醋到瓶口，浸泡一个月，这时醋醋几乎全部被大豆吸收，然后晾晒干燥，放在粉碎机中粉碎，用100至200目筛网过滤，制成醋黑豆粉；（2）大枣去核洗净，焙干，黑芝麻洗净炒熟，桑叶洗净晾干，黑木耳洗净晾干，酒炙丹参切片洗净晾干，红薯叶洗净晾干，绞股兰洗净晾干，将上述材料放入粉碎机中粉碎，用100至200目筛网过筛制成粉剂；（3）将步骤2和步骤3中制成的粉剂和在一起，混合均匀后用橄榄油调好干湿度，以使粉剂能滚成团，用10目筛网过筛，制成颗粒后在阴凉处晾晒，使其干燥；（4）将步骤3中晾晒干燥后的颗粒按10克一袋真空包装，制成成品。
实施例3：一种降三高保健食品，其特征在于按重量份计，其原料配比包括醋黑豆60份，大枣5份，黑芝麻5份，桑叶5份，黑木耳20份，葛根粉20份，罗布麻15份，酒炙丹参3份，红薯叶20份，绞股蓝25份，橄榄油适量，其制备步骤包括：（1）将黑豆洗净，去除杂质，用开水过两遍后沥干水分，放入大口容器内，不超过容积的三分之二，然后加入米醋到瓶口，浸泡一个月，这时醋醋几乎全部被大豆吸收，然后晾晒干燥，放在粉碎机中粉碎，用100至200目筛网过滤，制成醋黑豆粉；（2）大枣去核洗净，焙干，黑芝麻洗净炒熟，桑叶洗净晾干，黑木耳洗净晾干，酒炙丹参切片洗净晾干，红薯叶洗净晾干，绞股兰洗净晾干，并共同消毒，将上述材料放入粉碎机中粉碎，用100至200目筛网过筛制成粉剂；（3）将步骤2和步骤3中制成的粉剂和在一起，混合均匀后用橄榄油调好干湿度，以使粉剂能滚成团，用10目筛网过筛，制成颗粒后在阴凉处晾晒，使其干燥；（4）将步骤3中晾晒干燥后的颗粒按10克一袋真空包装，制成成品。
实施例4典型案例：
吴某，男，患高血压多年，每日坚持饮食上述实施例1中的保健食品两袋，多长时间血压测量显示明显下降，继续坚持每天2袋饭后用热水冲泡，1个星期后，测量血压恢复正常 ，目前，每天坚持吃至少1包。
王某，女，40多岁，患糖尿病8年，服降糖药期间，血糖一般控制在7-10个左右，每日坚持加服上述实施例2中的保健食品两袋，连续服用3天后测血糖，血糖明显下降至6.3-8.9间，使血糖得到了显著的降低。
崔某，男，患高血脂20多年，每日坚持服用上述实施例3中的保健食品1或2袋，1个月后检查，血脂的相关指数得到下降。
Claims (1)
1.一种降三高保健食品，其特征在于按重量份计，其原料配比包括醋黑豆40-60份，大枣5-15份，黑芝麻5-15份，桑叶5-15份，黑木耳20-40份，葛根粉20-40份，罗布麻5-15份，酒炙丹参3-10份，红薯叶10-20份，绞股蓝15-25份，橄榄油适量，
其制备步骤包括：（1）将黑豆洗净，去除杂质，用开水过两遍后沥干水分，放入大口容器内，不超过容积的三分之二，然后加入米醋到瓶口，浸泡一个月，这时醋醋几乎全部被大豆吸收，然后晾晒干燥，放在粉碎机中粉碎，用100至200目筛网过滤，制成醋黑豆粉；
（2）大枣去核洗净，焙干，黑芝麻洗净炒熟，桑叶洗净晾干，黑木耳洗净晾干，酒炙丹参切片洗净晾干，红薯叶洗净晾干，绞股兰洗净晾干，将上述材料放入粉碎机中粉碎，用100至200目筛网过筛制成粉剂；
（3）将步骤2和步骤3中制成的粉剂和在一起，混合均匀后用橄榄油调好干湿度，以使粉剂滚成团，用10目筛网过筛，制成颗粒后在阴凉处晾晒，使其干燥；
（4）将步骤3中晾晒干燥后的颗粒按10克一袋真空包装，制成成品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410679399.0A CN104323153A (zh) | 2014-11-24 | 2014-11-24 | 降三高保健食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410679399.0A CN104323153A (zh) | 2014-11-24 | 2014-11-24 | 降三高保健食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104323153A true CN104323153A (zh) | 2015-02-04 |
Family
ID=52398085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410679399.0A Pending CN104323153A (zh) | 2014-11-24 | 2014-11-24 | 降三高保健食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104323153A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106072645A (zh) * | 2016-06-29 | 2016-11-09 | 傅志勇 | 治疗三高的保健品及其制备方法与应用 |
| CN106262825A (zh) * | 2016-08-12 | 2017-01-04 | 雷应魁 | 一种心血管蔬菜保健配方胶囊及其制备方法 |
| CN106343343A (zh) * | 2016-08-29 | 2017-01-25 | 甘洛县彝家山寨农牧科技有限公司 | 一种降三高的多穗柯苦荞组合物及其应用 |
| CN106722208A (zh) * | 2017-01-12 | 2017-05-31 | 广州市何效德生物科技有限公司 | 一种蜜醋黑豆食品及其制备方法 |
| CN109430698A (zh) * | 2018-11-07 | 2019-03-08 | 广州小象健康产业有限公司 | 一种食疗调理肾结石的营养膳食及其制备方法和应用 |
| CN113519658A (zh) * | 2021-07-29 | 2021-10-22 | 冯大伟 | 一种降三高养生茶及其制备方法 |
-
2014
- 2014-11-24 CN CN201410679399.0A patent/CN104323153A/zh active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106072645A (zh) * | 2016-06-29 | 2016-11-09 | 傅志勇 | 治疗三高的保健品及其制备方法与应用 |
| CN106262825A (zh) * | 2016-08-12 | 2017-01-04 | 雷应魁 | 一种心血管蔬菜保健配方胶囊及其制备方法 |
| CN106343343A (zh) * | 2016-08-29 | 2017-01-25 | 甘洛县彝家山寨农牧科技有限公司 | 一种降三高的多穗柯苦荞组合物及其应用 |
| CN106722208A (zh) * | 2017-01-12 | 2017-05-31 | 广州市何效德生物科技有限公司 | 一种蜜醋黑豆食品及其制备方法 |
| CN109430698A (zh) * | 2018-11-07 | 2019-03-08 | 广州小象健康产业有限公司 | 一种食疗调理肾结石的营养膳食及其制备方法和应用 |
| CN113519658A (zh) * | 2021-07-29 | 2021-10-22 | 冯大伟 | 一种降三高养生茶及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
| CN1729874B (zh) | 一种桑叶桑椹菊花复合颗粒饮料的制备方法 | |
| CN101695328B (zh) | 一种石斛茶 | |
| CN104323153A (zh) | 降三高保健食品 | |
| CN102293273A (zh) | 可调节血压、血糖、血脂并预防血栓、中风的养生茶 | |
| CN103549052A (zh) | 一种美颜减肥茶及其制备方法 | |
| CN105077264A (zh) | 一种保健饮品组合物及其制备方法 | |
| CN107156363A (zh) | 一种具有减肥功效的复配茶及其制备方法 | |
| CN106819297A (zh) | 一种参杞花果茶及其制备方法 | |
| CN103349121B (zh) | 降三高保健茶及其制备方法 | |
| CN112603971B (zh) | 蛹虫草陈皮中药组合物、制备方法及其用途 | |
| CN104293552A (zh) | 一种减肥葡萄酒 | |
| CN109170014A (zh) | 一种石斛保健茶及其制备方法 | |
| CN102100275B (zh) | 一种决明子茶 | |
| CN103181437A (zh) | 罗布麻茶饮料 | |
| CN104798950A (zh) | 免疫功夫茶及其制备方法 | |
| CN103734855A (zh) | 适宜三高人群饮用的植物饮料及制备工艺 | |
| CN104095097A (zh) | 一种降压茶 | |
| CN103948021B (zh) | 一种滁菊明目保健颗粒剂及其生产方法 | |
| CN105851395A (zh) | 一种黄芪养生茶及其制备方法 | |
| CN1092935C (zh) | 薏米茶及其加工工艺 | |
| CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
| CN105341944A (zh) | 一种提高免疫力的丹参口服液及其制备方法 | |
| CN104719538B (zh) | 一种竹盐茶的制备方法 | |
| CN103829240B (zh) | 一种含龙眼壳、核浸提液的明目保健品及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150204 |
|
| RJ01 | Rejection of invention patent application after publication |